TP-417

N/A

Report date: 2025/01/26 15:37:54
NME

Base Information

Drug NameTP-417
Drug Alias Nameresolvin D1 (Thetis Pharmaceuticals)TP-417
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationImmune System DiseasesMultiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesThetis Pharmaceuticals Llc
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsInflammationMultiple Sclerosis
Inactive IndicationsImmune System Diseases

Other Information

ATC CodeN/A
Related LinksN/A